Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer

Springer Science and Business Media LLC - Tập 19 - Trang 1-11 - 2018
Qingzhou Guan1, Haidan Yan1, Yanhua Chen1, Baotong Zheng1, Hao Cai1, Jun He1, Kai Song2, You Guo1,3, Lu Ao1, Huaping Liu1, Wenyuan Zhao2, Xianlong Wang1, Zheng Guo1,4,2
1Fujian Key Laboratory of Medical Bioinformatics, Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China
2College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China
3Department of Preventive Medicine, School of Basic Medicine Sciences, Gannan Medical University, Ganzhou, China
4Fujian Key Laboratory of Tumor Microbiology, Fujian Medical University, Fuzhou, China

Tóm tắt

Due to experimental batch effects, the application of a quantitative transcriptional signature for disease diagnoses commonly requires inter-sample data normalization, which would be hardly applicable under common clinical settings. Many cancers might have qualitative differences with the non-cancer states in the gene expression pattern. Therefore, it is reasonable to explore the power of qualitative diagnostic signatures which are robust against experimental batch effects and other random factors. Firstly, using data of technical replicate samples from the MicroArray Quality Control (MAQC) project, we demonstrated that the low-throughput PCR-based technologies also exist large measurement variations for gene expression even when the samples were measured in the same test site. Then, we demonstrated the critical limitation of low stability for classifiers based on quantitative transcriptional signatures in applications to individual samples through a case study using a support vector machine and a naïve Bayesian classifier to discriminate colorectal cancer tissues from normal tissues. To address this problem, we identified a signature consisting of three gene pairs for discriminating colorectal cancer tissues from non-cancer (normal and inflammatory bowel disease) tissues based on within-sample relative expression orderings (REOs) of these gene pairs. The signature was well verified using 22 independent datasets measured by different microarray and RNA_seq platforms, obviating the need of inter-sample data normalization. Subtle quantitative information of gene expression measurements tends to be unstable under current technical conditions, which will introduce uncertainty to clinical applications of the quantitative transcriptional diagnostic signatures. For diagnosis of disease states with qualitative transcriptional characteristics, the qualitative REO-based signatures could be robustly applied to individual samples measured by different platforms.

Tài liệu tham khảo